NCT02087319

Brief Summary

The purpose of study is to examine the advantage of PRP on hair loss and male pattern baldness. The investigators will inject PRP into the scalp regions where with little or no hair, and evaluate the effect and efficiency of PRP on human hair growth.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 14, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

March 2, 2016

Status Verified

February 1, 2016

Enrollment Period

1.4 years

First QC Date

March 12, 2014

Last Update Submit

February 29, 2016

Conditions

Hair Loss/Baldness

Outcome Measures

Primary Outcomes (1)

  • examination the effect of PRP on hair loss/baldness

    We will track and evaluate regularly the effect and efficiency of PRP on human hair growing density and newly-formed hair length by phtography and measurement.

    1 month

Study Arms (1)

platelet-rich plasma

EXPERIMENTAL

hair loss, baldness

Other: hair loss, baldness (patient's own platelet-rich plasma)

Interventions

hair loss, baldness (patient's own platelet-rich plasma)OTHER

hair loss, baldness

platelet-rich plasma

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient with hair loss/baldness
  • age of 20-70 years old

You may not qualify if:

  • patient with systemic disorder
  • phyco
  • patient with coagulation abnormality
  • patient with inflammation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, Taiwan

Location

Study Officials

  • Jeng Long-Bin

    organ transplantation center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2014

First Posted

March 14, 2014

Study Start

January 1, 2014

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

March 2, 2016

Record last verified: 2016-02

Locations

TW(1)